CANF
Can-Fite BioPharma
CANF
CANF
6 hedge funds and large institutions have $2.39M invested in Can-Fite BioPharma in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+4
Holders Change %
+200%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.47M | 292,000 | +292,000 | New |
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $587K | 117,000 | +117,000 | New |
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $249K | 48,544 | +48,544 | New |
|
4
Morgan Stanley
New York
| $80K | 15,881 | +8,553 | +117% |
|
|
U
5
UBS
Zurich,
Switzerland
| $8K | 1,500 | +1,500 | New |
|
6
Citigroup
New York
| $2K | 400 | +400 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | – | -1,134 | Closed |
|